Alpha-1 Foundation

Alpha 1 Foundation

Research, 3300 Ponce De Leon Blvd., Coral Gables, Florida, 33134, United States, 11-50 Employees

alpha-1foundation.org

  • facebook
  • LinkedIn

phone no Phone Number: +13*********

Who is ALPHA-1 FOUNDATION

The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improving the lives of people affected by Alpha-1 worldwide. The Foundation is a ...

Read More

map
  • 3300 Ponce De Leon Blvd., Coral Gables, Florida, 33134, United States Headquarters: 3300 Ponce De Leon Blvd., Coral Gables, Florida, 33134, United States
  • 1995 Date Founded: 1995
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Research

SIC SIC Code: 8733 | NAICS Code: 541720 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ALPHA-1 FOUNDATION

Alpha-1 Foundation Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Alpha-1 Foundation

Answer: Alpha-1 Foundation's headquarters are located at 3300 Ponce De Leon Blvd., Coral Gables, Florida, 33134, United States

Answer: Alpha-1 Foundation's phone number is +13*********

Answer: Alpha-1 Foundation's official website is https://alpha-1foundation.org

Answer: Alpha-1 Foundation's revenue is $10 Million to $25 Million

Answer: Alpha-1 Foundation's SIC: 8733

Answer: Alpha-1 Foundation's NAICS: 541720

Answer: Alpha-1 Foundation has 11-50 employees

Answer: Alpha-1 Foundation is in Research

Answer: Alpha-1 Foundation contact info: Phone number: +13********* Website: https://alpha-1foundation.org

Answer: The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improving the lives of people affected by Alpha-1 worldwide. The Foundation is a not-for-profit Florida corporation founded in 1995 by John Walsh, Sandy Lindsey and Susan Stanley, three individuals diagnosed with Alpha-1. A majority of the Board of Directors are either diagnosed with Alpha-1 or have a family member diagnosed with Alpha-1. The Foundation has developed a solid infrastructure to promote research and development of new therapies for improving the quality of life for those diagnosed with Alpha-1. It has fostered collaborations with investigators throughout the United States and Europe, working closely with the National Institutes of Health, Food and Drug Administration, individuals affected by Alpha-1 and the pharmaceutical industry to expedite the development of improved therapies. The Foundation participates in industry and government liaison groups and develops strategic alliances with government, industry and other national and international health and research organizations. The Alpha-1 Foundation has invested more than $90 million to support Alpha-1 research and programs at 123 institutions in North America, Europe, the Middle East and Australia. The Foundation has established activities and programs including the Alpha-1 Research Registry, the Alpha-1 DNA & Tissue Bank, the Alpha-1 Research Network, International Scientific Conferences, and the Gordon L. Snider Critical Issues Workshop Series. Follow the Alpha-1 Foundation on social media for up-to-date Alpha-1 news and information: Facebook - Alpha1Foundation Twitter - alphafriend Instagram - Alpha1Foundation

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access